A Study to Evaluate the Effect of Lipid Infusion on Toll Like Receptor 4 (TLR4) Signaling

NCT01740817 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

12

Enrollment

OTHER

Sponsor class

Conditions

Diabetes
Obesity

Interventions

DRUG: Intralipid 20%
DRUG: Saline

Sponsor

The University of Texas Health Science Center at San Antonio

Collaborators

[object Object]